Parkinson's Disease
Parkinson's disease is a progressive neurological disorder that affects movement, causing symptoms such as tremors, stiffness, and difficulty with balance and coordination.
Cognitive Impairment in Parkinson's: Donepezil Study
We are studying whether donepezil can improve cognitive function in people with mild cognitive impairment due to Parkinson's disease. The trial will also evaluate its effects on mental health and quality of life.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 50 and 80 years old?
- Do you have a diagnosis of Parkinson's disease?
- Are you currently pregnant or breastfeeding?
- Have you been on the same Parkinson's medication for at least 4 weeks?
- Have you had any memory or thinking problems in the last 6 months?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Adtreat
Alertan
Alzepezil
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Hospital Universitario Fundacion Alcorcon
Neurology
Alcorcón, Spain
Hospital Germans Trias I Pujol
Neurology
Badalona, Spain
Hospital Universitario De Navarra
Neurology
Barañáin, Spain
Sponsor: Fundacio Institut De Recerca De L Hospital De La Santa Creu I Sant Pau
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.